ARTICLE | Company News

Janssen terminates deal with Chi-Med

August 21, 2015 1:09 AM UTC

Hutchison China MediTech Ltd. (AIM:HCM) said the Janssen Pharmaceutical Inc. unit of Johnson & Johnson (NYSE:JNJ) terminated an agreement with its Hutchison MediPharma Ltd. R&D unit to develop HMPL-507, a small molecule against an undisclosed target in the area of inflammation and immunology. ...